Regression of severe atherosclerotic plaque in patients with mild elevation of LDL cholesterol

Journal of Investigative Medicine

Volumn 45, Issue 9, 1997, Pages 536-541

  Schaefer, Saul ^a   Hussein, Hassan ^a   Gershony, Gary R ^a   Rutledge, John C ^a   Kappagoda, C Tissa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary artery disease; Excerise; Hyperlipidemia; Lipids; Progression; Quantitative angiography

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; DIET THERAPY; DISEASE COURSE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; KINESIOTHERAPY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; RISK FACTOR;

ADULT; AGED; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DIET THERAPY; DISEASE PROGRESSION; EXERCISE THERAPY; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0031301677     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Brown BG, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan CK, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-98.
2. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Bould KL. Can lifestyle changes reverse coronary heart disease?. Lancet 1990;336:129-33.
3. Watts GF, Lewis B, Brunt JNH, Lewis ES, Coltart DJ, Smith LDR, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992;339:563-9.
4. Kane JP, Malloy MJ, Posts TA, Phillips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990;264:3007-12.
5. Alderman EL, Haskell WL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP), [abstract]. Circulation 1994;84(II Suppl):140.
6. Lacoste L, Lam JYT, Hung J, Letchacovski G, Solymoss CB, Waters D. Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation 1995;92:3172-7.
7. Brensike JF, Levy RI, Kelsey SF, Passamani ER, Richardson JM, Loh IK, Friedewald W, Detre KM, Epstein SE. Effects of therapy with cholestyramine on progression of coronary atherosclerosis: Results of the NHLBI Type II coronary intervention study. Circulation 1984;69:313-24.
8. Arntzenius AC, Kromhout D, Barth JD, Reiber JH, Bruschke AV, Buis B, van Gent CM, Kempen-Voogd N, Strikwerda S, van der Velde EA. Diet, lipoproteins, and the progression of coronary atherosclerosis: the Leiden Intervention Trial. N Engl J Med 1985;312:805-11.
9. Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN, FrNort LWV, Mahrer PR, Masteller MJ, Vailes LI, et al. Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med 1993;119:969-76.
10. Cashin-Hemphill L, Mack WJ, Pogoda MJ, Sanmarco ME, Azen SP, Blankenhorn DH. Beneficial effects of colestipol-niacin on coronary atherosclerosis. JAMA 1990;264:3013-7.
11. Brown BG, Zhao X-Q, Sacco DE, Albers JJ. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993;87:1781-9.
12. Waters D, Higginson L, Gladstone P, Kimball B, LeMay M, Boccuzi SJ, et al. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. Circulation 1994;89:959-68.
13. Sacks FM, Pasternak RC, Gibson CM, Rosner B, Stone PH. Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP). Lancet 1994;344:1182-6.
14. Recommendations regarding public screening for measuring blood cholesterol. Summary of a National Heart, Lung, and Blood Institute workshop, October 1988. Arch Intern Med 1989;149:2650-4.
15. Pasternak RC, Brown LE, Stone PH, Silverman DI, Gibson CM, Sacks FM. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. Ann Intern Med 1997;125:529-40.
16. Sacks FM, Pfeffer MZ, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun C-C, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
17. Sacks FM, Gibson CM, Rosner B, Pasternak RC, Stone PH. The influence of pretreatment low density lipoprotein cholesterol concentrations on the effect of hyocholesterolemic therapy on coronary atherosclerosis in angiographic trials. Harvard Atherosclerosis Reversibility Project Research Group. Am J Cardiol 1995;76:78C-85C.
18. Richardson RD, Davies MJ, Born GVR. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989;11:941-4.
19. van der Waal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
20. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-503.
21. Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berke M, Fischer C, DeMaria AN. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991;84:1087-99.
22. Heinecke JW. Cellular mechanisms for the oxidative modification of lipoproteins: implications for atherogenesis. Coron Artery Dis 1994;5:205-10.
23. Blankenhorn DH, Hodis HN. Arterial imaging and atherosclerosis reversal. Arterioscler Thromb 1994;14:177-92.